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Patients with hepatic arteriovenous malformations rarely present with pulmonary hypertension. We
report the case of a 3-month-old boy who developed severe pulmonary hypertension due to a hepatic
arteriovenous malformation. The use of pulmonary vasodilators to treat the patient’s pulmonary hy-
pertension worsened his high-output heart failure. This is the ﬁrst case in which emergency hepatectomy
rescued a patient with hepatic arteriovenous malformations who developed pulmonary hypertension.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Hepatic arteriovenous malformations (HAVM) are congenital
vascular anomalies that are associated with signiﬁcant morbidity
and mortality rates, but the etiology of HAVM is poorly understood
due to their rarity [1e6]. Although HAVM can initially be silent,
complications including high-output heart failure, hemorrhaging,
embolisms, pain, or hepatomegaly will often occur later in life [1].
Patients with HAVM rarely present with severe persistent pulmo-
nary hypertension in early infancy [2e6]. However, increases in
pulmonary blood ﬂow due to large peripheral left-to-right shunts
such as HAVM can cause pulmonary arterial hypertension in the
presence of normal or even low pulmonary vascular resistance
(ﬂow-PAH) [7e9]. Most cases of pulmonary hypertension caused by
increased pulmonary vascular resistance are treated with pulmo-
nary vasodilators. However, treatment with pulmonary vasodila-
tors will worsen the symptoms of patients with high-output heart
failure associated with ﬂow-PAH. Therefore, the early diagnosis and
deﬁnitive treatment of HAVM-induced ﬂow-PAH are important for
reducing the high mortality rate of the condition.
1. Case report
A 1786 gmalewas delivered by Caesarean section at 34 weeks of
gestation at another hospital. An echocardiogram showed an atrialþ81 52 744 2980.
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Inc. This is an open access article useptal defect, and the child’s respiratory condition continued to
worsen. Although the patient underwent radical surgery for the
atrial septal defect at 3 months of age, his respiratory condition did
not improve after the operation, and a postoperative echocardio-
gram detected pulmonary hypertension. After postoperative
treatment with nitric oxide and prostaglandin I2, the patient’s
respiratory condition worsened considerably. A contrast-enhanced
computed tomography (CT) scan of the patient’s whole body was
performed and showed an arteriovenous malformation in the left
lobe of the liver (between multiple feeding vessels from the left
hepatic artery and a markedly dilated left hepatic vein) (Fig. 1). The
left and right hepatic arteries were normally bifurcated from the
proper hepatic artery. There were no ﬁndings of hypoperfusion on
the right lobe in spite of low resistance in the left hepatic artery. The
patient was referred to our hospital on the 11th day after the cardiac
surgery.
When he arrived at our hospital, he was intubated and exhibited
a partial pressure of arterial oxygen of 60e70 mm Hg under me-
chanical ventilation (inspiratory O2 fraction: 100%, positive end
expiratory pressure: 10 cm H2O, peak inspiratory pressure:
40 cm H2O). A chest X-ray showed bilateral pulmonary congestion.
An echocardiogram demonstrated that the atrial septal defect had
closed, but all of his pulmonary veins were markedly dilated, and
his estimated systolic pulmonary artery pressure was about
50 mm Hg. A blood test detected a very high brain natriuretic
peptide level (8334 pg/ml). On the other hands, the patient did not
present with liver dysfunction because his total bilirubinnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Contrast-enhanced CT. a and b: early arterial phase, c: late arterial phase. a: A 50  33 mmmass-like lesion containing dilated vessels was detected in the left lobe of the liver.
b and c: Multiple feeding arteries (arrow) and a markedly dilated left hepatic vein (arrowhead) were seen.
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alanine transaminase levels were 22 and 9 IU/l, and International
Normalized Ratio was 1.4. The patient was diagnosed with pul-
monary hypertension and high-output heart failure. We had a
conference with pediatric cardiologists and interventional radiol-
ogists regarding whether transcatheter embolization could be
performed to treat the patient’s HAVM; however, they suggested
that transcatheter arterial embolization would not effectively
improve his high output cardiac failure or ﬂow-PAH due to the
presence of multiple collateral arteries. In order to reduce the left-
to-right shunts as soon as possible, we performed an emergency
left hepatic lobectomy. The patient’s body weight was 3700 g at the
time of the operation.
During laparotomy, an arteriovenous malformation was seen in
the left lobe of liver, andmarkedly dilated vessels were observed on
the surface of the gallbladder (Fig. 2). The feeding vessels included
multiple vessels from the left hepatic artery and collateral arteries
from the regions surrounding the hepatoduodenal ligament and
left triangular ligament. After dealing with the feeding vessels, a
formal left hepatectomy was performed. The operation took
238 min and involved 665 ml of intraoperative blood loss. The
patient’s postoperative course was uneventful. After the operation,
the patient’s respiratory condition improved markedly, and he was
successfully extubated 6 days after the procedure. A postoperativeFig. 2. Surgical ﬁndings. An arteriovenous malformation was seen in the left lobe of liver (ar
(arrow).chest X-ray revealed that the patient’s pulmonary congestion had
improved, and an echocardiogram did not detect pulmonary hy-
pertension. A blood test performed on postoperative day 2 showed
that the patient’s brain natriuretic peptide level had normalized
(553 pg/ml). Although the postoperative liver function tests were
elevated temporarily (serum aspartate transaminase and alanine
transaminase levels on postoperative day 1 were 165 and 52 IU/l,
respectively), they were normalized 5 days after the procedure. He
was discharged in a healthy condition 13 days after the hepatec-
tomy. A follow-up examination performed at 16 months after the
hepatectomy demonstrated that the patient was asymptomatic,
and an abdominal CT scan did not show any abnormalities.
2. Discussion
Patients with HAVM rarely develop pulmonary hypertension in
early infancy [2e6]. Pulmonary hypertension is categorized into 5
groups: pulmonary arterial hypertension (Group 1; PAH), pulmo-
nary hypertension due to left heart disease (Group 2), pulmonary
hypertension due to chronic lung disease and/or hypoxia (Group 3),
chronic thromboembolic pulmonary hypertension (Group 4), and
pulmonary hypertension due to unclear multifactorial mechanisms
(Group 5) [7]. Most cases of pediatric pulmonary hypertension
involve PAH (Group 1). As the use of a speciﬁc threshold forrowhead), and markedly dilated vessels were observed on the surface of the gallbladder
Table 1
Reported cases of hepatic arteriovenous malformations combined with persistent pulmonary hypertension in early infancy.
Author Year Onset Location Other clinical presentations Treatment Outcome
Bamford 1980 At birth Left lobe HOHF Digoxin, furosemide Died on day 3
Paley 1997 1 month NA HOHF, skin hemangioma Hepatic artery ligation Died after 22 months
Paley 1997 6 months NA Hepatomegaly, skin hemangioma Embolization, liver transplantation Alive
Alexander 2006 At birth Left lobe HOHF Embolization Alive
Thatrimontrichai 2012 At birth Left lobe HOHF, skin hemangioma Embolization Died after 43 days
Agha 2015 At birth Left lobe HOHF Digoxin, furosemide, captopril Alive
Our case 2015 3 months Left lobe HOHF Hepatectomy Alive
NA: not available, HOHF: high-output heart failure.
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diagnostic criterion for PAH, Group 1 also includes patients with
pulmonary hypertension caused by increased pulmonary blood
ﬂow due to large left-to-right shunts (ﬂow-PAH), who can exhibit
normal pulmonary capillary wedge pressure levels and normal or
even low pulmonary vascular resistance [7,8]. In a study of a large
registry of patients with pediatric pulmonary hypertension con-
ducted in the Netherlands, it was found that 2845 of 3265 (87%)
pediatric patients with pulmonary hypertension had PAH. These
patients were divided into two categories according to their prog-
nosis; i.e., progressive PAH (n ¼ 154; 5%) and transient PAH
(n ¼ 2691; 82%) [9]. The patients with transient PAH included
numerous patients with ﬂow-PAH (n ¼ 1112). However, almost all
of the patients with ﬂow-PAH (n ¼ 1110) had congenital heart
defect-associated PAH, and there were few cases in which periph-
eral left-to-right shunts were an important component of the pa-
tient’s PAH [9]. In particular, ﬂow-PAH resulting fromHAVM in early
infancy seems to be very rare, and only 7 case reports (including
ours) about the condition were found in the literature [2e6]. Most
cases (6/7) were associated with high-output heart failure, and the
prognosis of HAVM-induced ﬂow-PAH is not very good as 43% of the
patients (3/7) died (Table 1). Our case is the ﬁrst in which emer-
gency hepatectomy rescued a patient with HAVM who developed
ﬂow-PAH.
Flow-PAH and PAH resulting from increased pulmonary vascular
resistance are poles apart in terms of pulmonary blood ﬂow, and it
is necessary to treat ﬂow-PAH with care because the use of pul-
monary vasodilators will worsen high-output heart failure associ-
ated with ﬂow-PAH [4]. In our case, the HAVM-induced ﬂow-PAH
could not be detected before the start of pulmonary vasodilator
treatment. However, it is possible that the emergency procedure
could have been avoided if pulmonary vasodilators had not been
used. Indeed, a neonatal case was reported in which medical
therapy in the form of diuretic agents and captopril improved
HAVM-induced ﬂow-PAH without the need for invasive procedures
[6].
Although no standardized recommendations for the manage-
ment of HAVM have been developed due to the rarity of the con-
dition, transcatheter embolization followed by surgical resection is
often employed [1]. In our case, we consulted interventional radi-
ologists and pediatric cardiologists, but they concluded that
transcatheter arterial embolization would not be effective against
our patient’s HAVM because embolizing the dominant feeding
vessels would lead to rapid enlargement of the minor feeding
vessels [10]. Transcatheter arterial embolization or ligation of the
proximal feeding arteries is only temporarily effective, and the
rapid recruitment of collateral arteries makes further treatment
difﬁcult or impossible [10,11]. Emergency hepatectomy is associ-
ated with signiﬁcant risks, especially in small, sick infants. If our
patient presented with preoperative liver dysfunction, the post-
operative course might be troublesome. However, emergencyhepatectomy is sometimes the only deﬁnitive treatment for cases of
HAVM involving urgent complications. Among the literature, we
found a case in which hepatectomy was performed for a hepatic
arterioportal malformation and intestinal hypoperfusion in a
neonate (2700 g) [12].
In conclusion, HAVM-induced ﬂow-PAH is rare in early infancy.
However, care should be takenwhen treating ﬂow-PAH because the
standard treatment for PAH resulting from increased pulmonary
vascular resistance; i.e., the administration of a pulmonary vaso-
dilator, can worsen high-output heart failure. Emergency hepatec-
tomy is an effective treatment for HAVM-induced ﬂow-PAH, even in
small, sick infants.
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